- Home
- ELUT
ELUT
Elutia Inc.
as of 03-13-2026 3:34pm EST
$1.09
$0.06
-5.65%
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | SILVER SPRING |
| Market Cap: | 46.5M | IPO Year: | 2020 |
| Target Price: | $6.00 | AVG Volume (30 days): | 189.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.66 | EPS Growth: | 10.14 |
| 52 Week Low/High: | $0.50 - $3.46 | Next Earning Date: | N/A |
| Revenue: | $24,375,000 | Revenue Growth: | -1.50% |
| Revenue Growth (this year): | 26.95% | Revenue Growth (next year): | 24.84% |
| P/E Ratio: | -1.74 | Index: | N/A |
| Free Cash Flow: | -23311000.0 | FCF Growth: | N/A |
AI-Powered ELUT Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 2 days ago
AI Recommendation
hold
Model Accuracy: 75.49%
75.49%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Elutia Inc. (ELUT)
RAKIN KEVIN
Buy
Director, 10% Owner
ELUT Jan 30, 2026
Avg Cost/Share
$1.06
Shares
70,000
Total Value
$74,200.00
Owned After
196,120
SEC Form 4
NEELS GUIDO J
Buy
Director
ELUT Jan 30, 2026
Avg Cost/Share
$1.04
Shares
20,000
Total Value
$20,800.00
Owned After
118,750
SEC Form 4
NEELS GUIDO J
Buy
Director
ELUT Jan 29, 2026
Avg Cost/Share
$1.06
Shares
15,000
Total Value
$15,900.00
Owned After
118,750
SEC Form 4
NEELS GUIDO J
Buy
Director
ELUT Jan 28, 2026
Avg Cost/Share
$1.06
Shares
15,000
Total Value
$15,900.00
Owned After
118,750
SEC Form 4
Makes Brigid
Buy
Director
ELUT Dec 17, 2025
Avg Cost/Share
$0.52
Shares
25,000
Total Value
$13,000.00
Owned After
27,000
SEC Form 4
Ferguson Matthew
Buy
CHIEF FINANCIAL OFFICER
ELUT Dec 17, 2025
Avg Cost/Share
$0.53
Shares
60,000
Total Value
$31,800.00
Owned After
447,110
SEC Form 4
Mills C Randal
Buy
PRESIDENT AND CEO
ELUT Dec 17, 2025
Avg Cost/Share
$0.51
Shares
3,000
Total Value
$1,530.00
Owned After
379,204
SEC Form 4
RAKIN KEVIN
Buy
Director, 10% Owner
ELUT Dec 17, 2025
Avg Cost/Share
$0.52
Shares
50,000
Total Value
$25,995.00
Owned After
196,120
SEC Form 4
Colpman David
Buy
Director
ELUT Dec 17, 2025
Avg Cost/Share
$0.51
Shares
12,500
Total Value
$6,375.00
Owned After
31,098
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| RAKIN KEVIN | ELUT | Director, 10% Owner | Jan 30, 2026 | Buy | $1.06 | 70,000 | $74,200.00 | 196,120 | |
| NEELS GUIDO J | ELUT | Director | Jan 30, 2026 | Buy | $1.04 | 20,000 | $20,800.00 | 118,750 | |
| NEELS GUIDO J | ELUT | Director | Jan 29, 2026 | Buy | $1.06 | 15,000 | $15,900.00 | 118,750 | |
| NEELS GUIDO J | ELUT | Director | Jan 28, 2026 | Buy | $1.06 | 15,000 | $15,900.00 | 118,750 | |
| Makes Brigid | ELUT | Director | Dec 17, 2025 | Buy | $0.52 | 25,000 | $13,000.00 | 27,000 | |
| Ferguson Matthew | ELUT | CHIEF FINANCIAL OFFICER | Dec 17, 2025 | Buy | $0.53 | 60,000 | $31,800.00 | 447,110 | |
| Mills C Randal | ELUT | PRESIDENT AND CEO | Dec 17, 2025 | Buy | $0.51 | 3,000 | $1,530.00 | 379,204 | |
| RAKIN KEVIN | ELUT | Director, 10% Owner | Dec 17, 2025 | Buy | $0.52 | 50,000 | $25,995.00 | 196,120 | |
| Colpman David | ELUT | Director | Dec 17, 2025 | Buy | $0.51 | 12,500 | $6,375.00 | 31,098 |
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K BUY Mar 11, 2026 · 100% conf.
2025
Q4
Q4 2025 Earnings
8-K BUYMar 11, 2026 · 100% conf.
AI Prediction BUY
1D
+5.50%
$0.73
Act: +26.34%
5D
+15.15%
$0.79
Act: +22.32%
20D
+14.27%
$0.79
Act: +37.98%
Price: $0.69 Prob +5D: 100% AUC: 1.000
0001104659-26-026398
ELUTIA INC._March 3, 2026 0001708527false00017085272026-03-032026-03-03
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 3, 2026
ELUTIA INC.
(Exact name of registrant as specified in its charter)
Delaware 001-39577 47-4790334
(State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)
20 Firstfield Road Gaithersburg, MD 20878 (Address of principal executive offices) (Zip Code) (240) 247-1170 (Registrant’s telephone number, include area code) N/A (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbols Name of each exchange on which registered
Class A Common Stock, $0.001 par value per share
ELUT
The Nasdaq Capital Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On March 11, 2026, Elutia Inc. (the “Company” or “Elutia”) issued a press release announcing its results for the fourth quarter and year ended December 31, 2025. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this Item 2.02 of this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing. Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. Exhibit Description
99.1 Press Release of Elutia Inc. dated March 11, 2026
104 Cover Page Interactive Data File (formatted as Inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ELUTIA INC.
Date: March 11, 2026 By: /s/ Matthew Ferguson
Matthew Ferguson
Chief Financial Officer
2025 Q4 Q4 2025 Earnings
8-K BUY Jan 12, 2026 · 100% conf.
2025
Q4
Q4 2025 Earnings
8-K BUYJan 12, 2026 · 100% conf.
AI Prediction BUY
1D
+5.50%
$0.73
Act: +26.34%
5D
+15.15%
$0.79
Act: +22.32%
20D
+14.27%
$0.79
Act: +37.98%
Price: $0.69 Prob +5D: 100% AUC: 1.000
0001104659-26-002742
ELUTIA INC._January 12, 2026 0001708527false00017085272026-01-122026-01-12
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 12, 2026
ELUTIA INC.
(Exact name of registrant as specified in its charter)
Delaware 001-39577 47-4790334
(State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)
20 Firstfield Road Gaithersburg, MD 20878 (Address of principal executive offices) (Zip Code) (240) 247-1170 (Registrant’s telephone number, include area code) N/A (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbols Name of each exchange on which registered
Class A Common Stock, $0.001 par value per share
ELUT
The Nasdaq Capital Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On January 12, 2026, Elutia Inc. (the “Company” or “Elutia”) issued a press release announcing its preliminary results for the fourth quarter ended December 31, 2025. The preliminary results are subject to normal year-end accounting closing and audit procedures. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this Item 2.02 of this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing. Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. Exhibit Description
99.1 Press Release of Elutia Inc., dated January 12, 2026
104 Cover Page Interactive Data File (formatted as Inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ELUTIA INC.
Date: January 12, 2026 By: /s/ Matthew Ferguson
Matthew Ferguson
Chief Financial Officer
2025 Q3 Q3 2025 Earnings
8-K Nov 6, 2025
2025
Q3
Q3 2025 Earnings
8-KNov 6, 2025
0001104659-25-107741
false 0001708527
0001708527
2025-11-06 2025-11-06
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 6, 2025
ELUTIA INC.
(Exact name of registrant as specified in its charter)
Delaware
001-39577
47-4790334
(State or other jurisdiction of
incorporation)
(Commission
File Number)
(IRS
Employer
Identification No.)
20 Firstfield Road, Gaithersburg,
MD 20878
(Address of principal executive offices) (Zip Code)
(240) 247-1170
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Class A Common Stock, $0.001 par value per share
ELUT
The Nasdaq Capital Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 2.02Results of Operations and Financial Condition.
On November 6, 2025, Elutia Inc. (the “Company” or “Elutia”) issued a press release announcing its results for the third quarter ended September 30, 2025. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The information in this Item 2.02 of this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
Item 9.01Financial Statements and Exhibits.
(d)Exhibits.
Exhibit No.
Exhibit Description
99.1
Press Release of Elutia Inc., dated November 6, 2025
104
Cover Page Interactive Data File (formatted as Inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ELUTIA INC.
(Registrant)
Date: November 6, 2025 By: /s/ Matthew Ferguson
Matthew Ferguson
Chief Financial Officer
Latest Elutia Inc. News
ELUT Breaking Stock News: Dive into ELUT Ticker-Specific Updates for Smart Investing
Argus Research
Daily – Vickers Top Insider Picks for 03/13/2026
GlobeNewswire
Elutia Reports Fourth Quarter and Full Year 2025 Financial Results; Initiates NXT-41 Regulatory Process
📈
AI Sentiment
Highly Positive
9/10
Argus Research
Daily – Vickers Top Insider Picks for 03/11/2026
Compare ELUT vs Leading Stocks
See how ELUT stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "ELUT Elutia Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.